Patent Assignment
Reel/Frame 074910/0274
Security Interest
Recorded: 2026-02-18
Pages: 43
Assignor
ORPHAI THERAPEUTICS INC.
Executed: 2026-02-17
Assignee
ACADIA WOODS PARTNERS, LLC, AS AGENT
77 BEDFORD ROAD, KATONAH, NEW YORK, 10536
Covered Properties
(49)
Inhalable Rapamycin Formulation for Treating Age-Related Conditions
Application:
18/643,988 →
Publication:
US US20240285524A1
Inhalable Rapamycin Formulation for the Treatment of Pulmonary Hypertension
Antiviral Compositions and Methods
Application:
18/281,942 →
Publication:
US US20240189317A1
Stabilized Apilimod Compositions and Uses Thereof
Application:
18/528,630 →
Publication:
US US20240374523A1
Stabilized Apilimod Compositions and Uses Thereof
Application:
18/410,608 →
Publication:
US 2024/0277720
Apilimod Compositions and Methods of Use
Anti-Viral Compositions and Methods of Use
Application:
17/248,696 →
Publication:
US US20210244743A1
An Inhalable Rapamycin Formulation for Treating Age-Related Conditions
Inhalable Rapamycin Formulation for Treating Age-Related Conditions
Inhalable Rapamycin Formulation for the Treatment of Pulmonary Hypertension
Rapamycin for the Treatment of Lymphangioleiomyomatosis
Rapamycin for the Treatment of Lymphangioleiomyomatosis
Rapamycin for the Treatment of Lymphangioleiomyomatosis
Rapamycin for the Treatment of Lymphangioleiomyomatosis
Rapamycin for the Treatment of Lymphangioleiomyomatosis
Combination Therapy with Apilimod and Glutamatergic Agents
Combination Therapy with Apilimod and Glutamatergic Agents
Combination Therapy with Apilimod and Glutamatergic Agents
Apilimod Compositions and Methods for Using Same
Apilimod Compositions and Methods for Using Same
Apilimod for Use in the Treatment of Melanoma
Apilimod for Use in the Treatment of Renal Cancer
Apilimod Compositions and Methods for Using Same in the Treatment of Renal Cancer
Combinations of a Mithramycin Analogue and Another Chemotherapeutic Agent for the Treatment of Triple Negative Breast Cancer
Aureolic Acid Derivatives, the Method for Preparation Thereof and the Uses Thereof
Antitumor Activity of Multi-Kinase Inhibitors in Colorectal Cancer
Antitumor Activity of Multi-Kinase Inhibitors in Triple Negative Breast Cancer
Glycosylated Indolecarbazoles, Method for Obtaining Same and Uses Thereof
Pyrimidine Compounds and Uses Thereof
Pyridine Compounds
Heteroaryl-Hydrazone Compounds
Fused Heterocyclic Compounds
Fused Hetrocyclic Compounds
Disalt Inhibitors of Il-12 Production
2-Substituted Heteroaryl Compounds
Process for Preparing Trisubstituted Pyrimidine Compounds
Heteroaryl Compounds
Il-12 Modulatory Compounds
Il-12 Modulatory Compounds
Il-12 Modulatory Compounds
Il-12 Modulatory Compounds
Compositions and Methods for Modulating C-Rel-Dependent Cytokine Production
Therapeutic Compounds and Their Use in Cancer
Purine-Core Inhibitors of HSP90 and Their Use in Treating Cancer
Use of Mithramycin Analogue for the Treatment of Cancer
PCT:
PCT/US2025/019734 ↗
Apilimod Compositions and Methods of Use
PCT:
PCT/US2024/040574 ↗
Apilimod Combination Therapy
PCT:
PCT/US2023/037275 ↗
Pikfyve Inhibitor Combination Therapy
PCT:
PCT/US2023/081184 ↗
Pikfyve Inhibitor Combination Therapy
PCT:
PCT/US2024/019449 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 10, 2017
From: LICHENSTEIN, HENRI; ROTHBERG, JONATHAN M.; ARMER, THOMAS; MELVIN, LAWRENCE S., JR.
To: LAM THERAPEUTICS, INC.
Reel/Frame 041538/0907 →
Assignment of Assignor's Interest
Sep 10, 2018
From: ARMER, THOMAS; MELVIN, LAWRENCE S., JR.; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 046824/0124 →
Assignment of Assignor's Interest
Sep 14, 2018
From: ARMER, THOMAS; MELVIN, LAWRENCE S., JR.; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 046876/0517 →
Assignment of Assignor's Interest
Sep 27, 2018
From: LICHENSTEIN, HENRI; ROTHBERG, JONATHAN M.; GAYLE, SOPHIA; BEEHARRY, NEIL
To: LAM THERAPEUTICS, INC.
Reel/Frame 046993/0660 →
Change of Name
Feb 26, 2019
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 048446/0249 →
Assignment of Assignor's Interest
Apr 4, 2019
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 048805/0306 →
Assignment of Assignor's Interest
Jun 30, 2020
From: LICHENSTEIN, HENRI; LANDRETTE, SEAN; YOUNG, PETER R.; ROTHBERG, JONATHAN M.
To: AI THERAPEUTICS, INC.
Reel/Frame 053090/0288 →
Change of Name
Mar 11, 2021
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 055560/0865 →
Change of Name
Mar 31, 2021
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 055790/0984 →
Assignment of Assignor's Interest
Mar 31, 2021
From: ARMER, THOMAS; MELVIN, LAWRENCE S., JR.; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 055785/0202 →
Assignment of Assignor's Interest
Jan 18, 2022
From: ARMER, THOMAS; MELVIN, LAWRENCE S., JR.; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 058678/0695 →
Change of Name
Jan 18, 2022
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 058926/0467 →
Assignment of Assignor's Interest
Jun 8, 2022
From: LICHENSTEIN, HENRI; LANDRETTE, SEAN; YOUNG, PETER; ROTHBERG, JONATHAN M.
To: AI THERAPEUTICS, INC.
Reel/Frame 060131/0685 →
Assignment of Assignor's Interest
Jul 25, 2022
From: LICHENSTEIN, HENRI; LANDRETTE, SEAN; YOUNG, PETER; ROTHBERG, JONATHAN M.
To: AI THERAPEUTICS, INC.
Reel/Frame 060602/0680 →
Change of Name
Sep 8, 2022
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 061397/0478 →
Change of Name
Sep 12, 2022
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 061410/0924 →
Assignment of Assignor's Interest
Sep 12, 2022
From: ARMER, THOMAS; MELVIN, LAWRENCE S., JR.; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 061062/0973 →
Change of Name
Jan 13, 2023
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 062388/0628 →
Assignment of Assignor's Interest
Jan 13, 2023
From: ARMER, THOMAS; MELVIN, LAWRENCE S., JR.; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 062372/0265 →
Assignment of Assignor's Interest
Jul 19, 2023
From: LICHENSTEIN, HENRI; ROTHBERG, JONATHAN M.; ARMER, THOMAS; MELVIN, LAWRENCE S., JR.
To: LAM THERAPEUTICS, INC.
Reel/Frame 064317/0952 →
Change of Name
Jul 31, 2023
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 064435/0869 →
Assignment of Assignor's Interest
Jul 31, 2023
From: ARMER, THOMAS; MELVIN, JR., LAWRENCE S.; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 064435/0438 →
Change of Name
Aug 2, 2023
From: LAM THERAPEUTICS, INC.
To: AI THERAPEUTICS, INC.
Reel/Frame 064473/0958 →
Assignment of Assignor's Interest
Aug 23, 2023
From: YOUNG, PETER RONALD
To: AI THERAPEUTICS, INC.
Reel/Frame 064684/0874 →
Assignment of Assignor's Interest
Sep 21, 2023
From: LANDRETTE, SEAN; YOUNG, PETER R.; LICHENSTEIN, HENRI; GUNEL, MURAT
To: AI THERAPEUTICS, INC.
Reel/Frame 064987/0988 →